Document 0100
 DOCN  M9460100
 TI    Costs to business for an HIV-infected worker.
 DT    9408
 AU    Farnham PG; Gorsky RD; Office of the Associate Director, HIV/AIDS,
       Centers for Disease; Control and Prevention, Atlanta, GA.
 SO    Inquiry. 1994 Spring;31(1):76-88. Unique Identifier : AIDSLINE
       MED/94222505
 AB    We use a Markov model to calculate the expected medical, disability,
       employee replacement, life insurance, and pension costs to a business
       firm for an HIV-infected employee. This analysis differs from previous
       HIV/AIDS cost analyses because we take the perspective of a business
       firm rather than of society, and we focus on the expected costs over a
       time frame relevant for business decision making. The maximum expected
       five-year cost to a business firm for an HIV-infected employee is
       estimated at $32,000, with an average expected cost of $17,000. These
       expected employment-based costs are less than the lifetime medical AIDS
       costs to society for an individual, which are estimated at more than
       $85,000. Employment-based costs are most influenced by the type of
       benefits provided under employer-based health insurance plans.
 DE    Commerce/ECONOMICS  Comparative Study  *Cost of Illness  Decision
       Making, Organizational  Disabled  Employer Health Costs/*STATISTICS &
       NUMER DATA  Health Benefit Plans, Employee/*ECONOMICS  Human  HIV
       Infections/*ECONOMICS  Inservice Training/ECONOMICS  Insurance,
       Life/ECONOMICS  *Markov Chains  Models, Statistical  Pensions  Personnel
       Turnover/ECONOMICS  United States  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).